Cargando…
Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report
Antagonists of tumour necrosis factor α (TNFα) are a common therapeutic choice for autoimmune diseases. Although they are effective and relatively safe, an increasing number of immune-mediated adverse events have been reported. Among these, neurological adverse effectsm such as consisting of demyeli...
Autores principales: | Iovino, Aniello, Aruta, Francesco, Dubbioso, Raffaele, Ruggiero, Lucia, Tozza, Stefano, Spina, Emanuele, Manganelli, Fiore, Iodice, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755935/ https://www.ncbi.nlm.nih.gov/pubmed/33424233 http://dx.doi.org/10.1177/1179573520973820 |
Ejemplares similares
-
The neuropathy in hereditary transthyretin amyloidosis: A narrative review
por: Tozza, Stefano, et al.
Publicado: (2021) -
Value of Antibody Determinations in Chronic Dysimmune Neuropathies
por: Tozza, Stefano, et al.
Publicado: (2022) -
The impact of symptoms on daily life as perceived by patients with Charcot-Marie-Tooth type 1A disease
por: Tozza, Stefano, et al.
Publicado: (2021) -
Alemtuzumab in Covid era
por: Iovino, Aniello, et al.
Publicado: (2021) -
One-year follow up of three Italian patients with Duchenne muscular
dystrophy treated with ataluren: is earlier better?
por: Ruggiero, Lucia, et al.
Publicado: (2018)